Literature DB >> 20381566

Disparity in circulating peripheral blood dendritic cell subsets and cytokine profile of pulmonary tuberculosis patients compared with healthy family contacts.

Vinay Gupta1, Anand Jaiswal, Digamber Behera, Hanumanthappa K Prasad.   

Abstract

Dendritic cell (DC) subsets, myeloid DCs (mDCs), and plasmacytoid DCs (pDCs) play a fundamental role in immune response to Mycobacterium tuberculosis (M. tuberculosis). Flow-cytometric estimation of DC subsets showed differences in the ratio of these subsets in untreated, smear-positive pulmonary tuberculosis patients compared with healthy family contacts (HFC, p < 0.05). The percentage of pDCs (0.14 +/- 0.01) was higher than mDCs (0.12 +/- 0.01) in patients, whereas in HFC, mDCs (0.15 +/- 0.01) was higher than pDCs (0.1 +/- 0.01). The percentage of mDCs (0.15 +/- 0.01) and pDCs (0.11 +/- 0.01) was restored in treated patients. Alteration in the DC subsets before and after chemotherapy was confirmed in the follow-up of acid-fast bacilli (AFB)-positive patients. This reversal in the percentage of mDC vs pDCs implicates the influence of active disease on circulating DC subsets. The cytokine bead array revealed an inverse relationship in the circulating levels of IL-12 and IFN-gamma. High IL-12 (37.9 +/- 15.2) and low IFN-gamma (11.09 +/- 3.6) was seen in HFCs derived serum samples compared with that of patients (p < 0.05). The higher percentage of mDCs and elevated IL-12 levels was found to be associated with high risk HFCs investigated. Furthermore CpG/LPS-stimulated whole-blood culture of untreated patients expressed high IFN-alpha in pDCs and less IL-12 in mDCs compared with those of treated patients. Copyright 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381566     DOI: 10.1016/j.humimm.2010.03.010

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Role of dendritic cells in the pathogenesis of Whipple's disease.

Authors:  Katina Schinnerling; Anika Geelhaar-Karsch; Kristina Allers; Julian Friebel; Kristina Conrad; Christoph Loddenkemper; Anja A Kühl; Ulrike Erben; Ralf Ignatius; Verena Moos; Thomas Schneider
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

2.  Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL-12Rβ2 promoter in Indian tuberculosis patients.

Authors:  Vikas Kumar Verma; Vibha Taneja; Anand Jaiswal; Sangeeta Sharma; Digamber Behera; Vishnubhatla Sreenivas; Shyam Singh Chauhan; Hanumanthappa Krishna Prasad
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

3.  Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis.

Authors:  Stefania Parlato; Teresa Chiacchio; Debora Salerno; Linda Petrone; Luciano Castiello; Giulia Romagnoli; Irene Canini; Delia Goletti; Lucia Gabriele
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

4.  Characterization of dendritic cell and regulatory T cell functions against Mycobacterium tuberculosis infection.

Authors:  Devin Morris; Brenda Gonzalez; Melissa Khurasany; Christine Kassissa; Jennifer Luong; Sarah Kasko; Shalin Pandya; Michael Chu; Po-Ting Chi; Steven Bui; Carlos Guerra; John Chan; Vishwanath Venketaraman
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

5.  Virulence-Dependent Alterations in the Kinetics of Immune Cells during Pulmonary Infection by Mycobacterium tuberculosis.

Authors:  Woo Sik Kim; Jong-Seok Kim; Seung Bin Cha; Seung Jung Han; HongMin Kim; Kee Woong Kwon; So Jeong Kim; Seok-Yong Eum; Sang-Nae Cho; Sung Jae Shin
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

6.  Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?

Authors:  Rina La Distia Nora; Ratna Sitompul; Marleen Bakker; Marjan A Versnel; Sigrid M A Swagemakers; Peter J van der Spek; Made Susiyanti; Lukman Edwar; Soedarman Sjamsoe; Gurmeet Singh; Rr Diah Handayani; Aniki Rothova; P Martin van Hagen; Willem A Dik
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.